Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

WEST PHARMACEUTICAL SERVICES INC Director's Dealing 2013

Nov 5, 2013

30339_dirs_2013-11-05_fe7146c7-7a7b-4ed1-94e9-b8ba7bfbf9eb.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2013-11-04

Reporting Person: LUZZI RICHARD D (Sr. VP, Human Resources)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2013-11-04 Common Stock M 22000.0000 $12.7650 Acquired 107501.0803 Direct
2013-11-04 Common Stock M 16708.0000 $16.2925 Acquired 124209.0803 Direct
2013-11-04 Common Stock S 16708.0000 $46.9944 Disposed 107501.0803 Direct
2013-11-04 Common Stock S 22000.0000 $46.9944 Disposed 85501.0803 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2013-11-04 Stock Option (Right to Buy) $16.2925 M 16708.0000 Disposed 2016-02-24 Common Stock (16708.0000) Direct
2013-11-04 Stock Option (Right to Buy) $12.7650 M 22000.0000 Disposed 2015-03-09 Common Stock (22000.0000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 952.7700 Indirect
Common Stock 22622.8264 Indirect

Footnotes

F1: Reflects additional shares purchased through dividend reinvestments based on most recent plan statement.